Showing 581 - 600 results of 9,864 for search '"drug"', query time: 0.08s Refine Results
  1. 581

    Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs by Simšič Tilen, Planinšek Odon, Baumgartner Ana

    Published 2024-06-01
    “…However, a major challenge that persists is effectively masking the bitter taste of drugs in such formulations. This review therefore provides a brief overview of the current state of the art in taste masking techniques, with a particular focus on taste masking by film coating. …”
    Get full text
    Article
  2. 582
  3. 583
  4. 584
  5. 585
  6. 586

    Do Nonsteroidal Anti-Inflammatory Drugs Affect Bone Healing? A Critical Analysis by Ippokratis Pountos, Theodora Georgouli, Giorgio M. Calori, Peter V. Giannoudis

    Published 2012-01-01
    “…Nonsteroidal anti-inflammatory drugs (NSAIDs) play an essential part in our approach to control pain in the posttraumatic setting. …”
    Get full text
    Article
  7. 587
  8. 588
  9. 589
  10. 590
  11. 591

    Integrating pharmacogenomics and cheminformatics with diverse disease phenotypes for cell type-guided drug discovery by Arda Halu, Sarvesh Chelvanambi, Julius L. Decano, Joan T. Matamalas, Mary Whelan, Takaharu Asano, Namitra Kalicharran, Sasha A. Singh, Joseph Loscalzo, Masanori Aikawa

    Published 2025-01-01
    “…Abstract Background Large-scale pharmacogenomic resources, such as the Connectivity Map (CMap), have greatly assisted computational drug discovery. However, despite their widespread use, CMap-based methods have thus far been agnostic to the biological activity of drugs as well as to the genomic effects of drugs in multiple disease contexts. …”
    Get full text
    Article
  12. 592

    Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens? by E. Pontali, M. Raviglione

    Published 2024-11-01
    “…In June 2024, WHO released ‘Key updates to the treatment of drug-resistant tuberculosis: rapid communication’, after the preliminary publication of results from two clinical trials: ‘BEAT-Tuberculosis’ and ‘endTB’. …”
    Get full text
    Article
  13. 593

    Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer by Jiabing Wang, Haoqian Xu, Ying Wang, Long Feng, Fengming Yi

    Published 2023-01-01
    “…Background. The drug-eluting beads transarterial chemoembolization (DEB-TACE) has already been used in hepatic malignancies. …”
    Get full text
    Article
  14. 594
  15. 595
  16. 596
  17. 597

    Estimation of the Secondary Attack Rate for Delta Hepatitis Coinfection among Injection Drug Users by Christiane Poulin, Theresa Gyorkos, Lawrence Joseph

    Published 1993-01-01
    “…The secondary attack rate for delta hepatitis coinfection was estimated among a cluster of injection drug users (IDUs). The infections occurred during an epidemic of hepatitis B in a rural area of Nova Scotia in 1988 and 1989. …”
    Get full text
    Article
  18. 598

    Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes by Qiang Su, Wei Kuang, Weiyi Hao, Jing Liang, Liang Wu, Chunmei Tang, Yali Wang, Tao Liu

    Published 2021-01-01
    “…Patients being treated for pulmonary tuberculosis often suffer liver injury due to the effects of anti-TB drugs, and the underlying mechanisms for those injuries need to be clarified. …”
    Get full text
    Article
  19. 599
  20. 600

    Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges by Maria Adriana Rangel, Isabel Pinto Pais, Raquel Duarte, Isabel Carvalho

    Published 2017-01-01
    “…The authors present a case report of antituberculosis drug-induced liver injury that offered diagnostic challenges (namely, the possibility of drug-induced autoimmune hepatitis) and treatment difficulties.…”
    Get full text
    Article